Literature DB >> 25835092

Spinal cord toxoplasmosis in human immunodeficiency virus infection/acquired immunodeficiency syndrome.

Concepción García-García1, Federico Castillo-Álvarez, José M Azcona-Gutiérrez, María J Herraiz, Valvanera Ibarra, José A Oteo.   

Abstract

Neurological complications in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome (HIV/AIDS) are still common, even in the era of highly active antiretroviral therapy. Opportunistic infections, immune reconstitution, the virus itself, antiretroviral drugs and neurocognitive disorders have to be considered when establishing the differential diagnosis. Toxoplasmic encephalitis remains the major cause of space-occupying lesions in the brain of patients with HIV/AIDS; however, spinal cord involvement has been reported infrequently. Here, we review spinal cord toxoplasmosis in HIV infection and illustrate the condition with a recent case from our hospital. We suggest that most patients with HIV/AIDS and myelitis with enhanced spine lesions, multiple brain lesions and positive serology for Toxoplasma gondii should receive immediate empirical treatment for toxoplasmosis, and a biopsy should be performed in those cases without clinical improvement or with deterioration.

Entities:  

Keywords:  AIDS; HIV; myelitis; spinal cord disease; toxoplasmosis

Mesh:

Year:  2015        PMID: 25835092     DOI: 10.3109/00365548.2014.993421

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  3 in total

1.  HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation.

Authors:  Manmeet K Mamik; Elizabeth Hui; William G Branton; Brienne A McKenzie; Jesse Chisholm; Eric A Cohen; Christopher Power
Journal:  J Neuroimmune Pharmacol       Date:  2016-10-10       Impact factor: 4.147

2.  Longitudinally Extensive Transverse Myelitis Due to Toxoplasma: An Autopsy Study.

Authors:  Yareeda Sireesha; Megha S Uppin; Komal Bohra; Rajesh Alugolu; Mathukumalli L Neeharika; Angamuthu Kanikannan
Journal:  Ann Indian Acad Neurol       Date:  2018 Apr-Jun       Impact factor: 1.383

Review 3.  Advances and Challenges in Understanding Cerebral Toxoplasmosis.

Authors:  Dirk Schlüter; Antonio Barragan
Journal:  Front Immunol       Date:  2019-02-14       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.